Evidence map›Paper›PMID 37113636›Full record

ArticleClinical case reports2023

HAV-induced acalculous cholecystitis: A case report and literature review.

Faranak Salajegheh, Sara Shafieipour, Zohre Najminejad, Pouria Pourzand, Mohsen Nakhaie, Samaneh Jahangiri, Roham Sarmadian, Abolfazl Gilani, Mohammad Rezaei Zadeh Rukerd

Open access · goldAbstract readCase Reports
In one paragraph

Article in Clinical case reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Faranak SalajeghehClinical Research Development Unit, School of Medicine Afzalipour Hospital, Kerman University of Medical Sciences Kerman Iran.
Sara ShafieipourPhysiology Research Center, Institute of Neuropharmacology Kerman University of Medical Sciences Kerman Iran.
Zohre NajminejadEndocrinology and Metabolism Research Center, Institute of Basic and Clinical Physiology Sciences Kerman University of Medical Sciences Kerman Kerman Iran.
Pouria PourzandSchool of Medicine Zahedan University of Medical Sciences Zahedan Iran.
Mohsen NakhaieGastroenterology and Hepatology Research Center, Institute of Basic and Clinical Physiology Sciences Kerman University of Medical Sciences Kerman Iran.
Samaneh JahangiriClinical Research Development Unit, School of Medicine Afzalipour Hospital, Kerman University of Medical Sciences Kerman Iran.
Roham SarmadianInfectious disease research center Arak University of Medical Sciences Arak Iran.
Abolfazl GilaniDepartment of pediatric surgery Tehran university of Medical Sciences Tehran Iran.ORCID https://orcid.org/0000-0002-0762-4815
Mohammad Rezaei Zadeh RukerdGastroenterology and Hepatology Research Center, Institute of Basic and Clinical Physiology Sciences Kerman University of Medical Sciences Kerman Iran.ORCID https://orcid.org/0000-0001-8390-4344
Kerman University of Medical Sciences · IRArak University of Medical Sciences · IRTehran University of Medical Sciences · IRZahedan University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepatitis A virus (HAV) has some life-threatening extrahepatic complications, such as acute acalculous cholecystitis (AAC). We present HAV-induced AAC in a young female, based on clinical, laboratory, and imaging findings, and conduct a literature review. The patient became irritable, which progressed to lethargy, as well as a significant decline in liver function, indicating acute liver failure (ALF). She was immediately managed in the intensive care unit with close airway and hemodynamic monitoring after being diagnosed with ALF (ICU). The patient's condition was improving, despite only close monitoring and supportive treatment with ursodeoxycholic acid (UDCA) and N-acetyl cysteine (NAC).

Indexed as

acalculous cholecystitisHAV‐induced AACHepatitis A virus

Identifiers

PMID37113636
PMCPMC10127462
OpenAlexW4366993135

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.